Robeco Institutional Asset Management B.V. Has $7.63 Million Stake in GE HealthCare Technologies Inc. $GEHC

Robeco Institutional Asset Management B.V. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 238.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 101,634 shares of the company’s stock after purchasing an additional 71,567 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in GE HealthCare Technologies were worth $7,633,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its position in shares of GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares during the period. Glenview Trust co boosted its position in GE HealthCare Technologies by 4.4% during the 1st quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after acquiring an additional 139 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $259,000. Strs Ohio bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $30,001,000. Finally, Modern Wealth Management LLC raised its holdings in shares of GE HealthCare Technologies by 26.0% in the first quarter. Modern Wealth Management LLC now owns 3,014 shares of the company’s stock valued at $243,000 after purchasing an additional 621 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. The Goldman Sachs Group restated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a report on Friday. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Morgan Stanley upped their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Seven analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $89.50.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $87.28 on Friday. The business’s 50 day moving average price is $80.30 and its two-hundred day moving average price is $76.66. The company has a market cap of $39.76 billion, a PE ratio of 18.03, a price-to-earnings-growth ratio of 3.43 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.